These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28748474)

  • 1. Absolute Quantification of Toxicological Biomarkers via Mass Spectrometry.
    Lau TYK; Collins BC; Stone P; Tang N; Gallagher WM; Pennington SR
    Methods Mol Biol; 2017; 1641():337-348. PubMed ID: 28748474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute quantification of toxicological biomarkers by multiple reaction monitoring.
    Lau TY; Collins BC; Stone P; Tang N; Gallagher WM; Pennington SR
    Methods Mol Biol; 2011; 691():417-27. PubMed ID: 20972768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
    Mermelekas G; Vlahou A; Zoidakis J
    Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry.
    Ruhaak LR; van der Burgt YE; Cobbaert CM
    Expert Rev Proteomics; 2016 Dec; 13(12):1063-1071. PubMed ID: 27798968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.
    Whiteaker JR; Zhao L; Zhang HY; Feng LC; Piening BD; Anderson L; Paulovich AG
    Anal Biochem; 2007 Mar; 362(1):44-54. PubMed ID: 17241609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway-Informed Discovery and Targeted Proteomic Workflows Using Mass Spectrometry.
    Chu CS; Miller CA; Gieschen A; Fischer SM
    Methods Mol Biol; 2017; 1550():199-221. PubMed ID: 28188532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers.
    Chen L; Smith J; Mikl J; Fryer R; Pack F; Williams BJ; Phillips JA; Papov VV
    Chem Res Toxicol; 2017 Oct; 30(10):1823-1834. PubMed ID: 28885000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.
    Kitteringham NR; Jenkins RE; Lane CS; Elliott VL; Park BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1229-39. PubMed ID: 19041286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.
    Sajic T; Liu Y; Aebersold R
    Proteomics Clin Appl; 2015 Apr; 9(3-4):307-21. PubMed ID: 25504613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
    Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
    Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed Immunoaffinity Enrichment of Peptides with Anti-peptide Antibodies and Quantification by Stable Isotope Dilution Multiple Reaction Monitoring Mass Spectrometry.
    Kuhn E; Carr SA
    Methods Mol Biol; 2016; 1410():135-67. PubMed ID: 26867743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in targeted proteomics for clinical applications.
    Domon B; Gallien S
    Proteomics Clin Appl; 2015 Apr; 9(3-4):423-31. PubMed ID: 25504492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers.
    Han B; Higgs RE
    Brief Funct Genomic Proteomic; 2008 Sep; 7(5):340-54. PubMed ID: 18579614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MS-Based Proteomics of Body Fluids: The End of the Beginning.
    Bader JM; Albrecht V; Mann M
    Mol Cell Proteomics; 2023 Jul; 22(7):100577. PubMed ID: 37209816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture system.
    Guingab-Cagmat JD; Newsom K; Vakulenko A; Cagmat EB; Kobeissy FH; Zoltewicz S; Wang KK; Anagli J
    Electrophoresis; 2012 Dec; 33(24):3786-97. PubMed ID: 23161537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.